← Back to Search
Nanomedical Innovation: The SEON-concept For An Improved Cancer Therapy With Magnetic Nanoparticles.
S. Lyer, R. Tietze, H. Unterweger, J. Zaloga, R. Singh, Jasmin Matuszak, Marina Poettler, R. Friedrich, Stephan Duerr, I. Cicha, C. Janko, C. Alexiou
Published 2015 · Medicine, Materials Science
Download PDFAnalyze on Scholarcy
Nanomedicine offers tremendous opportunities for the development of novel therapeutic and diagnostic tools. During the last decades, extensive knowledge was gained about stabilizing and the coating of nanoparticles, their functionalization for drug binding and drug release and possible strategies for therapies and diagnostics of different diseases. Most recently, more and more emphasis has been placed on nanotoxicology and nanosafety aspects. The section of experimental oncology and nanomedicine developed a concept for translating this knowledge into clinical application of magnetic drug targeting for the treatment of cancer and other diseases using superparamagnetic iron oxide nanoparticles. This approach includes reproducible synthesis, detailed characterization, nanotoxicological testing, evaluation in ex vivo models, preclinical animal studies and production of superparamagnetic iron oxide nanoparticles according to good manufacturing practice regulations.
This paper references
Quantitative targeting maps based on experimental investigations for a branched tube model in magnetic drug targeting
K. Gitter (2011)
Synthesis of monodisperse iron oxide nanocrystals by thermal decomposition of iron carboxylate salts.
W. W. Yu (2004)
Nanotechnology as a therapeutic tool to combat microbial resistance.
Robert Y. Pelgrift (2013)
The cytotoxicity of polycationic iron oxide nanoparticles: Common endpoint assays and alternative approaches for improved understanding of cellular response mechanism
C. Hoskins (2012)
Visualisation of tumour regression after local chemotherapy with magnetic nanoparticles - a pilot study.
S. Lyer (2010)
Mitoxantrone Loaded Superparamagnetic Nanoparticles for Drug Targeting: A Versatile and Sensitive Method for Quantification of Drug Enrichment in Rabbit Tissues Using HPLC-UV
R. Tietze (2010)
Mr Lymphography Using Iron Oxide Particles
M. Taupitz (1993)
Magnetic Drug Targeting Reduces the Chemotherapeutic Burden on Circulating Leukocytes
C. Janko (2013)
Development and characterization of magnetic iron oxide nanoparticles with a cisplatin-bearing polymer coating for targeted drug delivery
H. Unterweger (2014)
Drug loaded magnetic nanoparticles for cancer therapy
R. Jurgons (2006)
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
A. Gupta (2005)
Sterically stabilized water based magnetic fluids : Synthesis, structure and properties
D. Bica (2007)
Visualization of superparamagnetic nanoparticles in vascular tissue using XμCT and histology
R. Tietze (2011)
Magnetorelaxometry for localization and quantification of magnetic nanoparticles for thermal ablation studies.
H. Richter (2010)
Integrin-Linked Kinase Controls Microtubule Dynamics Required for Plasma Membrane Targeting of Caveolae
S. Wickström (2010)
In vitro toxicity evaluation of single walled carbon nanotubes on human A549 lung cells.
M. Davoren (2007)
Sol-gel synthesis and electrospraying of biodegradable (P2O5)55-(CaO)30-(Na2O)15 glass nanospheres as a transient contrast agent for ultrasound stem cell imaging.
F. Foroutan (2015)
Monitoring of implanted stem cell migration in vivo: A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat
M. Hoehn (2002)
Stabilization and functionalization of iron oxide nanoparticles for biomedical applications.
E. Amstad (2011)
In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species
D. Andes (2010)
Different Storage Conditions Influence Biocompatibility and Physicochemical Properties of Iron Oxide Nanoparticles
Jan Zaloga (2015)
Microcomputed tomography analysis of ferrofluids used for cancer treatment.
H. Rahn (2008)
Gold nanoparticles enable selective light-induced contents release from liposomes.
Lauri Paasonen (2007)
Magnetic nanoparticles for cancer therapy
Stephan Duerr (2013)
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.
J. Ferlay (2013)
Efficient drug-delivery using magnetic nanoparticles--biodistribution and therapeutic effects in tumour bearing rabbits.
R. Tietze (2013)
Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications.
S. Laurent (2008)
Analysis of trajectories for targeting of magnetic nanoparticles in blood vessels.
A. Heidsieck (2012)
Adsorption of organic acids on magnetite nanoparticles, pH-dependent colloidal stability and salt tolerance
E. Tombácz (2013)
Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications.
L. H. Reddy (2012)
Solid Lipid Nanoparticles as Drug Delivery System for Water-Insoluble Drugs
Rihua Li (2010)
Real-time cell analysis of human cancer cell lines after chemotherapy with functionalized magnetic nanoparticles.
Stephan Duerr (2012)
Small-Angle X-ray Scattering Investigations of Biomolecular Confinement, Loading, and Release from Liquid-Crystalline Nanochannel Assemblies.
A. Angelova (2012)
Particle size, magnetic field, and blood velocity effects on particle retention in magnetic drug targeting.
E. Cherry (2010)
A comprehensive model of magnetic particle motion during magnetic drug targeting
E. Cherry (2014)
Delivery of superparamagnetic nanoparticles for local chemotherapy after intraarterial infusion and magnetic drug targeting.
C. Alexiou (2007)
Treatment of rabbit liver cancer in vivo using miniaturized image-ablate ultrasound arrays.
T. Mast (2011)
The influence of hydrodynamic diameter and core composition on the magnetoviscous effect of biocompatible ferrofluids.
J. Nowak (2014)
IN VITRO CULTIVATION AND IMMUNOFLUORESCENT STUDIES OF TRANSPLANTABLE CARCINOMAS Vx2 AND Vx7
T. Osato (1967)
Locoregional cancer treatment with magnetic drug targeting.
C. Alexiou (2000)
Understanding platinum-induced ototoxicity.
T. Langer (2013)
Hyaluronic acid immobilized magnetic nanoparticles for active targeting and imaging of macrophages.
M. Kamat (2010)
Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges
S. Laurent (2014)
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.
A. Lübbe (1996)
Flow cytometry for intracellular SPION quantification: specificity and sensitivity in comparison with spectroscopic methods
R. Friedrich (2015)
Identification of aggregates of magnetic nanoparticles in ferrofluids at low concentrations
D. Eberbeck (2003)
A High Field Gradient Magnet for Magnetic Drug Targeting
C. Alexiou (2006)
Shear stress preconditioning modulates endothelial susceptibility to circulating TNF-alpha and monocytic cell recruitment in a simplified model of arterial bifurcations.
I. Cicha (2009)
Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting
C. Alexiou (2001)
Magnetic targeting for site-specific drug delivery: applications and clinical potential
B. Polyak (2009)
Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility
J. Zaloga (2014)
Nanomedicine: magnetic nanoparticles and their biomedical applications.
R. Banerjee (2010)
Cytotoxicity of iron oxide nanoparticles made from the thermal decomposition of organometallics and aqueous phase transfer with Pluronic F127.
Marcela Gonzales (2010)
The potential environmental impact of engineered nanomaterials
V. Colvin (2003)
Thermoablation of Malignant Kidney Tumors Using Magnetic Nanoparticles: An In Vivo Feasibility Study in a Rabbit Model
P. Bruners (2009)
Medical applications of magnetic nanoparticles.
C. Alexiou (2006)
The effect of nanoparticle size, shape, and surface chemistry on biological systems.
Alexandre Albanese (2012)
Risk assessment of engineered nanomaterials: a review of available data and approaches from a regulatory perspective
D. Hristozov (2012)
Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents.
K. Widder (1979)
Preclinical experiences with magnetic drug targeting: tolerance and efficacy.
A. Lübbe (1996)
Combination of vascular endothelial growth factor antisense oligonucleotide therapy and radiotherapy increases the curative effects against maxillofacial VX2 tumors in rabbits.
Lin-feng Zheng (2011)
3-Dimensional quantitative detection of nanoparticle content in biological tissue samples after local cancer treatment
H. Rahn (2014)
A combined theoretical and in vitro modeling approach for predicting the magnetic capture and retention of magnetic nanoparticles in vivo.
A. David (2011)
In vitro investigation of the behaviour of magnetic particles by a circulating artery model
C. Seliger (2007)
The emerging field of nanotoxicology
C. Haynes (2010)
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.
M. Harisinghani (2003)
Cell "vision": complementary factor of protein corona in nanotoxicology.
M. Mahmoudi (2012)
Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats.
K. Widder (1983)
Cardiovascular therapy through nanotechnology – how far are we still from bedside?
I. Cicha (2014)
INFECTIOUS PAPILLOMATOSIS OF RABBITS : WITH A NOTE ON THE HISTOPATHOLOGY
R. E. Shope (1933)
Noninvasive mapping of pancreatic inflammation in recent-onset type-1 diabetes patients
J. Gaglia (2015)
Nanomaterial cell interactions: are current in vitro tests reliable?
C. Hirsch (2011)
Impact of the nanoparticle-protein corona on colloidal stability and protein structure.
J. Gebauer (2012)
Human serum albumin coated iron oxide nanoparticles for efficient cell labeling.
Jin Y. Xie (2010)
Real-time cellular analysis as a novel approach for in vitro cytotoxicity testing of medical device extracts.
Sandra N Garcia (2013)
Quantification of magnetic nanoparticles by magnetorelaxometry and comparison to histology after magnetic drug targeting.
F. Wiekhorst (2006)
Endothelial biocompatibility and accumulation of SPION under flow conditions
Jasmin Matuszak (2015)
Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles.
S. Laurent (2011)
Biomedical applications of magnetic fluids II. 1) preparation and magnetic guidance of magnetic albumin microsphere for site specific drug delivery in vivo.
Y. Morimoto (1981)
In vitro and in vivo investigations of targeted chemotherapy with magnetic nanoparticles
C. Alexiou (2005)
Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line.
N. Monteiro-Riviere (2009)
Lipid nanoparticles for the delivery of poorly water‐soluble drugs
H. Bunjes (2010)
Magnetorelaxometric quantification of magnetic nanoparticles in an artery model after ex vivo magnetic drug targeting.
H. Richter (2009)
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
G. Storm (1995)
Magnetism in Medicine
M. W. Freeman (1960)
TOPICAL REVIEW: Progress in applications of magnetic nanoparticles in biomedicine
Q. Pankhurst (2009)
Detection and enrichment of disseminated renal carcinoma cells from peripheral blood by immunomagnetic cell separation
U. Bilkenroth (2001)
Negative preclinical results with stealth nanospheres-encapsulated Doxorubicin in an orthotopic murine brain tumor model.
I. Brigger (2004)
TOPICAL REVIEW: Applications of magnetic nanoparticles in biomedicine
Q. Pankhurst (2003)
This paper is referenced by
Magnetic stem cell targeting to the inner ear
T. N. Le (2017)
Magnetic Drug Delivery: Where the Field Is Going
Paige M. Price (2018)
Zero-Field and Field-Induced Interactions between Multicore Magnetic Nanoparticles
A. A. Kuznetsov (2019)
Pharmaceutical formulation of HSA hybrid coated iron oxide nanoparticles for magnetic drug targeting.
J. Zaloga (2016)
Quo vadis nanomedicine?
M. Barz (2015)
Externally Induced Drug Release Systems with Magnetic Nanoparticle Carriers: An Emerging Field in Nanomedicine
Matthew D. Norris (2019)
A Bio-Chemosynthetic Approach to Superparamagnetic Iron Oxide-Ansamitocin Conjugates for Use in Magnetic Drug Targeting.
Liang-liang Wang (2017)
SPECIAL FOCUS y Part 1 y Quo vadis nanomedicine: past, present and future
Matthias Barz (2015)
Synthesis of Magnetic-Nanoparticle/Ansamitocin Conjugates-Inductive Heating Leads to Decreased Cell Proliferation In Vitro and Attenuation Of Tumour Growth In Vivo.
K. Seidel (2017)
Studies on the adsorption and desorption of mitoxantrone to lauric acid/albumin coated iron oxide nanoparticles.
J. Zaloga (2018)
Analysis of Hypericin-Mediated Effects and Implications for Targeted Photodynamic Therapy
L. Mühleisen (2017)
Strategies to optimize the biocompatibility of iron oxide nanoparticles – “SPIONs safe by design”
C. Janko (2017)
SPIONs functionalized with small peptides for binding of lipopolysaccharide, a pathophysiologically relevant microbial product.
Weronika Karawacka (2019)
Innovative toxikologische Untersuchungsmethoden für Eisenoxidnanopartikel in der Nanomedizin
C. Janko (2017)